Listeria Meningitis After Treatment With Infliximab
- 1 April 2002
- journal article
- case report
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 34 (4) , 410-412
- https://doi.org/10.1097/00005176-200204000-00018
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Invasive Pulmonary Aspergillosis Associated with Infliximab TherapyNew England Journal of Medicine, 2001
- Infliximab induces potent anti‐inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn’s diseaseAlimentary Pharmacology & Therapeutics, 2001
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Listeria monocytogenes in Crohn's DiseaseScandinavian Journal of Gastroenterology, 1998
- Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in miceImmunity, 1995
- Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.Gut, 1993
- Tumor Necrosis Factor and IL-1β Expression in Pediatric Patients with Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 1993
- Human tumor necrosis factor increases the resistance against Listeria infection in miceMedical Microbiology and Immunology, 1989
- LISTERIOSIS DURING PREGNANCY AND NEONATAL PERIOD IN SWEDEN 1958–1974Acta Paediatrica, 1979